[9]
Malhotra, M.; Jain, N.K. Niosomes as drug carriers. Indian Drugs, 1994, 31, 81-86.
[13]
Mujoriya, R.Z.; Dhamande, K.; Bodla, R.B. Niosomal drug delivery system: A review. Int J Appl Pharm., 2011, 3, 7-10.
[18]
Walve, J.R.; Bakliwal, S.R.; Rane, B.R.; Pawar, S.P. Transfersomes: A surrogated carrier for transdermal drug delivery system. Int. J. Appl. Biol. Pharm. Technol., 2011, 2, 204-213.
[19]
Sachan, R.; Parashar, T.; Soniya, S.V.; Singh, G.; Tyagi, S.; Patel, C.; Gupta, A. Drug carrier transfersomes: A novel tool for transdermal drug delivery system. Int. J. Res. Dev. Pharm. Life Sci., 2013, 2, 309-316.
[20]
Sivannarayana, P.; Rani, A.P.; Saikishore, V. VenuBabu, C.; SriRekha, V. Transfersomes: Ultra deformable vesicular carrier systems in transdermal drug delivery system. Res. J. Pharm. Dos. Forms Technol., 2012, 4, 243-255.
[21]
Bhasin, B.; Londhe, V.Y. An overview of transfersomal drug delivery. Int. J. Pharm. Sci. Res., 2018, 9, 2175-2184.
[24]
Akiladevi, D.; Sachinandan, B. Ethosomes a noninvasive approach for transdermal drug delivery. Int. J. Curr. Pharm. Res., 2010, 2(4), 1-4.
[25]
Sudhakar, C.K.; Upadhyay, N.; Jain, S.; Charyulu, R.N. Ethosomes as non-invasive loom for transdermal drug delivery system.Nanomedicine and Drug Delivery; 1st ed; Sebastian, M.; Ninan, N.; Haghi, A.K., Eds.; Apple Academic Press: New York, 2012, p. 1-22.
[43]
Sun, M.; Han, J.; Guo, X.; Li, Z.; Yang, J.; Zhang, Y.; Zhang, D. Design, preparation and in vitro evaluation of paclitaxel-loaded self-nanoemulsifying drug delivery system. Asian J. Pharm. Sci, 2011, 6(1), 18-25.
[45]
Dilip, K.P.; Surendra, T.; Suresh, K.N.; Roohi, K. Nanostructured lipid carrier (nlc) a modern approach for topical delivery: A review. World J. Pharm. Pharm. Sci., 2003, 2(3), 921-938.
[47]
Alclantar, N.; Williams, E.C.; Toomey, R. Adjuvant and vaccine compositions. US 2010/0226932A1, 2010.
[48]
Gail, S.; Shenoy, D.B.; Lee, R.W. Compositions for applying active substances to or through the skin. US5540934A, 2010.
[49]
Touitou, E. Formulation for delivery of insulin and preparation method thereof. WO2002064115A1, 1996.
[50]
Jeong, S.; Kwon, I.; Chung, H. Formulation for delivery of insulin and preparation method thereof. US20130034538A1, 2002.
[51]
Garti, N.; Aserin, D.L.; Amar-Yuli, I.; Tehila, M.; Liron, B. Reverse hexagonal mesophases (hii) and uses thereof. US20130034538A1, 2013.
[52]
Lebouille, G.J.; Kockelkoren, T.; Vleugels, F.; Remco, T. Micelle compositions and process for the preparation thereof. CA2791559A1, 2011.
[53]
Maurel, J. Reverse micelles based on phytosterols and acylglycerols and therapeutic uses thereof. US20090087406A1, 2009.
[54]
Lirio, Q.; Clark, D.; McKellar, A.J. Nanoemulsions. US8822385B2, 2014.
[55]
Mansoor, K.; Nazzal, S. Eutectic-based self-nanoemulsified drug delivery system. US7588786B2, 2009.